Literature DB >> 6478561

The effect of left ventricular systolic function on maximal aerobic exercise capacity in asymptomatic patients with coronary artery disease.

A A Ehsani, D Biello, D R Seals, M B Austin, J Schultz.   

Abstract

The purpose of this study was to examine the relationship between maximal O2 uptake (VO2max) and left ventricular systolic function in patients with coronary artery disease. We studied 27 patients, age 50 +/- 10 years (mean +/- SD), who were asymptomatic and able to attain true VO2max. VO2max was defined by the leveling-off criterion and/or a respiratory exchange ratio of 1.15 or greater. Left ventricular ejection fraction was determined by gated cardiac blood pool imaging. In patients whose ejection fraction decreased with exercise, VO2max was 21 +/- 4 vs 27 +/- 4 ml/kg/min in those whose ejection fraction increased (p less than .001). Systolic blood pressure/end-systolic volume relation was shifted upward and to the right in the former group in response to peak exercise. In contrast, the pressure-volume relation was shifted upward and to the left in patients whose ejection fraction increased with exercise. Ejection fraction at rest did not correlate with VO2max. There was a significant but weak correlation between peak exercise ejection fraction and VO2max (r = .43, p less than .025). Left ventricular exercise reserve, i.e., the change in ejection fraction from rest to exercise, correlated with VO2max (r = .77, p less than .0002), maximal O2 pulse (r = .50, p less than .005), and maximal heart rate during treadmill exercise (r = .61, p less than .001). Maximal heart rate during treadmill exercise correlated with VO2max (r = .70, p less than .0002).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6478561     DOI: 10.1161/01.cir.70.4.552

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Association of Cardiorespiratory Fitness With Coronary Heart Disease in Asymptomatic Men.

Authors:  Jennifer C Gander; Xuemei Sui; James R Hébert; Linda J Hazlett; Bo Cai; Carl J Lavie; Steven N Blair
Journal:  Mayo Clin Proc       Date:  2015-10       Impact factor: 7.616

2.  Rationally engineered Troponin C modulates in vivo cardiac function and performance in health and disease.

Authors:  Vikram Shettigar; Bo Zhang; Sean C Little; Hussam E Salhi; Brian J Hansen; Ning Li; Jianchao Zhang; Steve R Roof; Hsiang-Ting Ho; Lucia Brunello; Jessica K Lerch; Noah Weisleder; Vadim V Fedorov; Federica Accornero; Jill A Rafael-Fortney; Sandor Gyorke; Paul M L Janssen; Brandon J Biesiadecki; Mark T Ziolo; Jonathan P Davis
Journal:  Nat Commun       Date:  2016-02-24       Impact factor: 14.919

3.  The cardiovascular determinants of physical function in patients with end-stage kidney disease on haemodialysis.

Authors:  Sherna F Adenwalla; Roseanne E Billany; Daniel S March; Gaurav S Gulsin; Hannah M L Young; Patrick Highton; Darren C Churchward; Robin Young; Alysha Careless; Clare L Tomlinson; Gerry P McCann; James O Burton; Matthew P M Graham-Brown
Journal:  Int J Cardiovasc Imaging       Date:  2020-11-30       Impact factor: 2.357

4.  Coronary microvascular function, insulin sensitivity and body composition in predicting exercise capacity in overweight patients with coronary artery disease.

Authors:  Anders Jürs; Lene Rørholm Pedersen; Rasmus Huan Olsen; Martin Snoer; Elizaveta Chabanova; Steen Bendix Haugaard; Eva Prescott
Journal:  BMC Cardiovasc Disord       Date:  2015-11-27       Impact factor: 2.298

5.  The Effect of Cardiac Rehabilitation Exercise Training on Cardiopulmonary Function in Ischemic Cardiomyopathy With Reduced Left Ventricular Ejection Fraction.

Authors:  Chul Kim; Hee Eun Choi; Young-Joon Lim
Journal:  Ann Rehabil Med       Date:  2016-08-24

6.  Association between baseline cardiovascular mechanics and exercise capacity in patients with coronary artery disease.

Authors:  Emre Aslanger; Benjamin Assous; Nicolas Bihry; Florence Beauvais; Damien Logeart; Alain Cohen-Solal
Journal:  Anatol J Cardiol       Date:  2015-11-18       Impact factor: 1.596

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.